Stocks Telegraph

ARTL Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:ARTL

Artelo Biosciences, Inc.

$1.16
-0.0299-2.51%
At Close 4:00 PM
60.16
BESG ScoreESG Rating

ARTL FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ARTL Income Statement


A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2023-09-302023-06-302023-03-312022-12-312022-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20232023202320222022
periodQ3Q2Q1Q4Q3
revenue00000
cost of revenue00000
gross profit00000
gross profit ratio00000
research and development expenses1.585M752.00K1.235M1.726M1.078M
general and administrative expenses1.029M1.032M1.057M1.75M1.316M
selling and marketing expenses00000
selling general and administrative expenses1.029M1.032M1.057M1.75M1.316M
other expenses00000
operating expenses2.449M1.784M2.292M3.476M2.394M
cost and expenses2.449M1.784M2.292M3.476M2.394M
interest income0002.00K0
interest expense00-124.00K-140.00K5.00K
depreciation and amortization2.614M-185.00K-124.00K-72.00K0
ebitda165.00K-1.969M-2.416M-3.476M-2.394M
ebitda ratio00000
operating income-2.614M-1.784M-2.292M-3.476M-2.394M
operating income ratio00000
total other income expenses net165.00K185.00K124.00K137.00K64.00K
income before tax-2.449M-1.599M-2.168M-3.339M-2.33M
income before tax ratio00000
income tax expense165.00K0-124.00K-140.00K-69.00K
net income-2.449M-1.599M-2.044M-3.199M-2.261M
net income ratio00000
eps-0.83-0.56-0.72-1.13-0.79
eps diluted-0.83-0.56-0.72-1.13-0.79
weighted average shs out2.949M2.856M2.856M2.833M2.849M
weighted average shs out dil2.949M2.856M2.856M2.833M2.849M
Graph

ARTL Balance Sheet


Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Graph

ARTL Cash Flow


A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2023-06-302023-03-312022-12-312022-09-302022-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20232023202220222022
periodQ2Q1Q4Q3Q2
deferred income tax00000
stock based compensation225.00K354.00K608.00K607.00K619.00K
change in working capital-62.00K-248.00K575.00K97.00K-113.00K
accounts receivables00000
inventory00000
accounts payables-231.00K-180.00K579.00K-42.00K-377.00K
other working capital169.00K-68.00K-4.00K139.00K264.00K
other non cash items-187.00K-124.00K-137.00K-70.00K-23.00K
net cash provided by operating activities-1.623M-2.186M-2.293M-1.696M-1.966M
investments in property plant and equipment00000
acquisitions net00000
purchases of investments-2.351M-5.803M-2.183M-7.855M-740.00K
sales maturities of investments2.75M8.002M3.979M4.775M4.725M
other investing activites00000
net cash used for investing activites399.00K2.199M1.796M-3.08M3.985M
debt repayment00-33.00K-10.00K-14.00K
common stock issued0018.396M0-18.396M
common stock repurchased00000
dividends paid00000
other financing activites00-18.229M10.00K18.276M
net cash used provided by financing activities-1.252M0134.00K8.00K-134.00K
effect of forex changes on cash27.00K15.00K115.00K-210.00K-113.00K
net change in cash-1.197M28.00K-248.00K-4.986M1.772M
cash at end of period5.719M6.916M6.888M7.136M12.122M
cash at beginning of period6.916M6.888M7.136M12.122M10.35M
operating cashflow-1.623M-2.186M-2.293M-1.696M-1.966M
capital expenditure00000
free cash flow-1.623M-2.186M-2.293M-1.696M-1.966M
Graph

Frequently Asked Questions

How did Artelo Biosciences, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ARTL generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Artelo Biosciences, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Artelo Biosciences, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2023.

Have ARTL's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ARTL incurred $2.45M worth of Operating Expenses, while it generated -$2.61M worth of Operating Income.

How much Net Income has ARTL posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Artelo Biosciences, Inc., the company generated -$2.45M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Artelo Biosciences, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Artelo Biosciences, Inc. as of the end of the last quarter was N/A.

What are ARTL's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ARTL had Total Net Receivables of N/A.

In terms of Total Assets and Current Assets, where did Artelo Biosciences, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ARTL were N/A, while the Total Assets stand at N/A.

As of the last quarter, how much Total Debt did Artelo Biosciences, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ARTL's debt was N/A at the end of the last quarter.

What were ARTL's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ARTL reported total liabilities of N/A.

How much did ARTL's Working Capital change over the last quarter?

Working Capital Change for ARTL was -$62.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

ARTL generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ARTL generated -$1.62M of Cash from Operating Activities during its recently reported quarter.

What was ARTL's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ARTL reported a -$1.20M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Login Form

OR
stockstelegraph

Join to access AI-powered insights from top Wall Street analysts.

Signup Form

OR
stockstelegraph

Log in to gain access to powerful insights powered by AI and Wallstreet analysts.

Reset Password Form

stockstelegraph

Subscribe to gain access to powerful insights powered by AI and Wallstreet analysts.

This feature is only available to Premium Users.

Subscribe Now